Arteriosclerosis and Thrombosis, Vol 11, 517-529, Copyright © 1991 by American Heart Association
ARTICLES |
S Hadcock, M Richardson, PD Winocour and MW Hatton
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Diabetes mellitus is a major risk factor for atherosclerosis. Since endothelial alteration is probably associated with the development of atherosclerosis, we questioned whether morphological evidence of endothelial injury could be observed during the first 6 months of diabetes induced by a single intravenous injection of alloxan in normally fed rabbits compared with age-matched controls. Diabetes (plasma glucose greater than 16 mM) was established by 5 days after alloxan injection. Endothelial alterations consistent with injury, including adhesion of white blood cells, platelets, and fibrin-like material to the endothelial surface, were seen in diabetic rabbit aortas by 2 weeks. These alterations became more severe during the next 6 months. Increased endothelial replication in diabetic vessels was shown by the uptake of tritium-labeled thymidine at 2 weeks and at 3 and 6 months. Hyperplasia of intimal smooth muscle cells progressed during 3 months after treatment. About one third of the diabetic rabbits also showed an elevated plasma cholesterol level, which correlated with increased intimal proliferation but not with endothelial injury or replication. The onset of alloxan-induced diabetes in rabbits is associated with nondenuding endothelial injury and subsequent intimal hypertrophy, changes that are consistent with atherogenesis.
This article has been cited by other articles:
![]() |
J. Zhou, L. May, P. Liao, P. L. Gross, and J. I. Weitz Inferior Vena Cava Ligation Rapidly Induces Tissue Factor Expression and Venous Thrombosis in Rats Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 863 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Stalker, Y. Gong, and R. Scalia The Calcium-Dependent Protease Calpain Causes Endothelial Dysfunction in Type 2 Diabetes Diabetes, April 1, 2005; 54(4): 1132 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lamharzi, C. B. Renard, F. Kramer, S. Pennathur, J. W. Heinecke, A. Chait, and K. E. Bornfeldt Hyperlipidemia in Concert With Hyperglycemia Stimulates the Proliferation of Macrophages in Atherosclerotic Lesions: Potential Role of Glucose-Oxidized LDL Diabetes, December 1, 2004; 53(12): 3217 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Vogl-Willis and I. J. Edwards High Glucose-Induced Alterations in Subendothelial Matrix Perlecan Leads to Increased Monocyte Binding Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 858 - 863. [Abstract] [Full Text] |
||||
![]() |
D. Browne, D. Meeking, K. Shaw, and M. Cummings Review: Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes -- pathogenesis and identification The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 27 - 34. [Abstract] [PDF] |
||||
![]() |
R. F Ammar Jr., D. D Gutterman, L. A Brooks, and K. C Dellsperger Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes Cardiovasc Res, August 18, 2000; 47(3): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Patricia, J. A. Kim, C. M. Harper, P. T. Shih, J. A. Berliner, R. Natarajan, J. L. Nadler, and C. C. Hedrick Lipoxygenase Products Increase Monocyte Adhesion to Human Aortic Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2615 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Tsao, J. Niebauer, R. Buitrago, P. S. Lin, B.-y. Wang, J. P. Cooke, Y-d. Ida Chen, and G. M. Reaven Interaction of Diabetes and Hypertension on Determinants of Endothelial Adhesiveness Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Patricia, R. Natarajan, A. N. Dooley, F. Hernandez, J.-L. Gu, J. A. Berliner, J. J. Rossi, J. L. Nadler, R. S. Meidell, and C. C. Hedrick Adenoviral Delivery of a Leukocyte-Type 12 Lipoxygenase Ribozyme Inhibits Effects of Glucose and Platelet-Derived Growth Factor in Vascular Endothelial and Smooth Muscle Cells Circ. Res., April 13, 2001; 88(7): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |